(Q37808715)

23 August 2017

Accuracy of diagnostic tests in multiple sclerosis--a systematic review (English)

1 reference

23 August 2017

0 references

1 reference

N Schäffler

1

1 reference

23 August 2017

S Köpke

2

1 reference

23 August 2017

L Winkler

3

1 reference

23 August 2017

S Schippling

4

1 reference

23 August 2017

M Inglese

5

1 reference

23 August 2017

K Fischer

6

1 reference

23 August 2017

C Heesen

7

1 reference

23 August 2017

language of work or name

English

0 references

publication date

11 November 2010

1 reference

Acta Neurologica Scandinavica

23 August 2017

1 reference

23 August 2017

124

1 reference

23 August 2017

3

1 reference

23 August 2017

151-164

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

23 August 2017

1 reference

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

The causal cascade to multiple sclerosis: a model for MS pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

'Time is brain' also in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Diagnostic criteria for multiple sclerosis: an historical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation".

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Differential diagnosis of suspected multiple sclerosis: a consensus approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Accuracy of magnetic resonance imaging for the diagnosis of multiple sclerosis: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Delayed visual evoked response in optic neuritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Multiple sclerosis: correlation between immunoglobulin-G in cerebrospinal fluid and brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Cerebrospinal fluid virus antibodies. A diagnostic indicator for multiple sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Clinical and demographic predictors of long-term disability in patients with relapsing-remitting multiple sclerosis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Development and validation of methods for assessing the quality of diagnostic accuracy studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

A search for new MRI criteria for dissemination in space in subjects with a clinically isolated syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Spinal cord MRI in clinically isolated optic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Early MRI in optic neuritis: the risk for clinically definite multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Conversion to multiple sclerosis after a clinically isolated syndrome of the brainstem: cranial magnetic resonance imaging, cerebrospinal fluid and neurophysiological findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Baseline MRI predicts future attacks and disability in clinically isolated syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

A prospective study on the predictive value of CSF oligoclonal bands and MRI in acute isolated neurological syndromes for subsequent progression to multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Sensitivities and predictive values of paraclinical tests for diagnosing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Correlation of clinical, magnetic resonance imaging, and cerebrospinal fluid findings in optic neuritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Callosal lesion predicts future attacks after clinically isolated syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

MRI characteristics are predictive for CDMS in monofocal, but not in multifocal patients with a clinically isolated syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Magnetic resonance imaging predictors of conversion to multiple sclerosis in the BENEFIT study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis according to baseline MRI findings: comparison of revised McDonald criteria and Swanton modified criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Evaluation of the 2005 McDonald MRI criteria for dissemination in space in Afro-Caribbean patients with clinically isolated syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

The predictive value of cerebrospinal fluid electrophoresis in 'possible' multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

The predictive value of CSF oligoclonal banding for MS 5 years after optic neuritis. Optic Neuritis Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: a prospective 2-year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Predicting multiple sclerosis at optic neuritis onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Long-term follow-up of isolated optic neuritis: the risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

New diagnostic criteria for multiple sclerosis: application in first demyelinating episode.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

The contribution of cerebrospinal fluid oligoclonal bands to the early diagnosis of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Do multimodal evoked potentials add information to MRI in clinically isolated syndromes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Practice parameter: the usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Systematic reviews of diagnostic test accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Evaluation of diagnostic procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

The effect of spectrum bias on the utility of magnetic resonance imaging and evoked potentials in the diagnosis of suspected multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

MRI criteria for MS in patients with clinically isolated syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Evidence based diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Prognosis - what does the clinician associate with this notion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Grading quality of evidence and strength of recommendations for diagnostic tests and strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Suspected multiple sclerosis - what to do? Evaluation of a patient information leaflet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

Specificity of Barkhof Criteria in Predicting Conversion to Multiple Sclerosis When Applied to Clinically Isolated Brainstem Syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

A three-year, multi-parametric MRI study in patients at presentation with CIS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01454.X

10.1111/J.1600-0404.2010.01454.X

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference